Author: WTN News

The recent purchase of JT Packard by Power Plus will give the Verona-based power supplier some key market advantages, but a pending courtroom showdown could mean even more. How much more? Perhaps as much as $30 million in new business, according to founder Jeff Cason. ...

A number of people are dismissing Tommy Thompson's presidential chances, but Inside Wisconsin columnist Tom Still has a hunch the former Wisconsin governor could make some hay in the 2008 Iowa caucuses. Still, a former political reporter, covered the caucuses in three presidential elections, and...

Jason Smith, a Wisconsin native educated at UW-Madison, is leveraging his East Coast venture capital connections to finance high-tech innovators in the Midwest. Smith, the director of Avolte Venture Fund Midwest, plans to finance companies in the make-or-break growth stage....

Search engine marketing campaigns are not meant to be created and left alone, they must be actively managed, according to Tech/Know columnist Troy Janisch. In fact, "SEM" campaigns should be managed and adjusted as assiduously as investment portfolios, Janisch writes. ...

Seven more companies, most of them start ups, have been qualified by the state Department of Commerce for the state's Angel Investor and Venture Fund Tax Credit programs. Under the programs, people who invest in these companies are eligible for state tax credits. ...

Municipal governments have to become more dynamic as costs go up for services and people tire of tax increases, observes columnist James Carlini. That starts with not viewing services, old or new, as just another "cost of doing business." ...

Tommy Thompson, two days after launching a presidential bid, is positioning himself as the "idea candidate" of the 2008 presidential race. At the recent Wisconsin Biotechnology and Medical Device Association annual conference, he outlined a few suggestions to speed the pace of electronic health record...

Advanced Cell Technology made headlines when it announced it had developed a technique to derive stem cells without killing embryos in the process, and later acknowledging that embryos did, indeed, die. But did the company, in exaggerating its claims, act unethically? Three Wisconsin scientists offered...